Dr Lalchandani Labs Ltd vs Sharma East India Hosp And Medical Research Ltd Stock Comparison

Home

Insights

Stock Comparison

Last Updated on: Nov 01, 2026

Key Highlights

The Latest Trading Price of Dr Lalchandani Labs Ltd is ₹ 6.95 as of 29 Oct 15:30 . The P/E Ratio of Dr Lalchandani Labs Ltd changed from 6 on March 2021 to 0 on March 2026 . This represents a CAGR of -100.00% over 6 yearsThe P/E Ratio of Sharma East India Hosp and Medical Research Ltd changed from 24.9 on March 2025 to 34.6 on March 2026 . This represents a CAGR of 17.88% over 2 years The Market Cap of Dr Lalchandani Labs Ltd changed from ₹ 6.02 crore on March 2021 to ₹ 0 crore on March 2026 . This represents a CAGR of -100.00% over 6 yearsThe Market Cap of Sharma East India Hosp and Medical Research Ltd changed from ₹ 24.42 crore on March 2025 to ₹ 33.94 crore on March 2026 . This represents a CAGR of 17.89% over 2 years The revenue of Dr Lalchandani Labs Ltd for the Jun '26 is ₹ 0 crore as compare to the Mar '26 revenue of ₹ 0 crore. This represent the decline of 0% The revenue of Sharma East India Hosp and Medical Research Ltd for the Jun '26 is ₹ 10.8 crore as compare to the Mar '26 revenue of ₹ 7.49 crore. This represent the growth of 44.19% The ebitda of Dr Lalchandani Labs Ltd for the Jun '26 is ₹ 0 crore as compare to the Mar '26 ebitda of ₹ 0 crore. This represent the decline of 0% The ebitda of Sharma East India Hosp and Medical Research Ltd for the Jun '26 is ₹ 0.9 crore as compare to the Mar '26 ebitda of ₹ 1.03 crore. This represent the decline of -12.62% The net profit of Dr Lalchandani Labs Ltd changed from ₹ 0 crore to ₹ 0 crore over 9 quarters. This represents a CAGR of 0.0% The net profit of Sharma East India Hosp and Medical Research Ltd changed from ₹ 0.25 crore to ₹ 0.26 crore over 9 quarters. This represents a CAGR of 1.76% The Dividend Payout of Dr Lalchandani Labs Ltd changed from 0 % on March 2021 to 0 % on March 2026 . This represents a CAGR of 0.0% over 6 yearsThe Dividend Payout of Sharma East India Hosp and Medical Research Ltd changed from 0 % on March 2021 to 0 % on March 2026 . This represents a CAGR of 0.0% over 6 years .

About Dr Lalchandani Labs Ltd

Dr Lalchandani Labs Limited was originally incorporated as Partnership Firm at New Delhi dated 15 September, 2011 in the name of Dr. A Lalchandani Pathology Laboratories.
Thereafter, the Partnership Firm was taken over by M/s Dr Lalchandani Labs Limited on 2nd August, 2017 issued by the Registrar of Companies, Delhi vide agreement dated 31st August, 2017.
The Firm was established by Dr. Arjan Lal Chandani and his son Mr. Mohit Lal Chandani as a Partnership Firm in the name of 'Dr. A Lalchandani Pathology Laboratories' in 2011 and in year 2017, they formed a Company in the name and style M/s Dr Lalchandani Labs Limited and took over the Partnership firm. The Company is a provider of diagnostic and related healthcare tests and services in Delhi/NCR. Through its integrated network, it offers patients and healthcare providers a broad range of diagnostic and related healthcare tests and services for use in core testing, patient diagnosis and the prevention, monitoring and treatment of disease and other health conditions.

About Sharma East India Hosp and Medical Research Ltd

Sharma East India Hospitals & Medical Research Limited was incorporated on November 16, 1989.
The Company is engaged in providing medical and healthcare services and real estate services and is presently running a multi-specialty hospital in the name of 'Jaipur Hospital' at Lal Kothi, at Rajasthan since 1989. As far as the achievements of the Company are concerned, the first assessment of the Company was conducted by National Accreditation Board for Hospitals and Health Care Providers (NABH), NABH accreditation system is one of the methods for commitment to quality enhancement throughout whole of the health care system in India.
It involves all professional and service groups to ensure that high quality in health care is achieved, while minimizing the inherent risks associated with modern health care delivery.

FAQs for the comparison of Dr Lalchandani Labs Ltd and Sharma East India Hosp and Medical Research Ltd

Which company has a larger market capitalization, Dr Lalchandani Labs Ltd or Sharma East India Hosp and Medical Research Ltd?

Market cap of Dr Lalchandani Labs Ltd is 6 Cr while Market cap of Sharma East India Hosp and Medical Research Ltd is 26 Cr

What are the key factors driving the stock performance of Dr Lalchandani Labs Ltd and Sharma East India Hosp and Medical Research Ltd?

The stock performance of Dr Lalchandani Labs Ltd and Sharma East India Hosp and Medical Research Ltd is primarily driven by its robust global client base, consistent revenue growth, strong operational efficiency, strategic investments in digital transformation, client acquisition, and the overall health of the industry. Both companies' performances are also influenced by macroeconomic conditions, currency fluctuations, and industry-specific trends.

What are the recent stock price for Dr Lalchandani Labs Ltd and Sharma East India Hosp and Medical Research Ltd?

As of November 1, 2026, the Dr Lalchandani Labs Ltd stock price is INR ₹6.95. On the other hand, Sharma East India Hosp and Medical Research Ltd stock price is INR ₹80.0.

How do dividend payouts of Dr Lalchandani Labs Ltd and Sharma East India Hosp and Medical Research Ltd compare?

To compare the dividend payouts of Dr Lalchandani Labs Ltd and Sharma East India Hosp and Medical Research Ltd, examine their dividend payout ratio, which indicates how much the companies pay out relative to their share price and earnings. Moreover, consider the consistency and growth of their dividends to gauge their commitment towards returning value to the respective shareholders.

Disclaimer: This information provided above is for informational purposes only and does not constitute investment advice. We use third-party data and recommend conducting thorough research and consulting a certified financial advisor before making investment decisions. We do not endorse specific stocks. Make decisions based on your own research and professional guidance.